Humanize Pharmaceuticals Private Limited
About Humanize Pharmaceuticals Private Limited
Data last updated:
Humanize Pharmaceuticals Private Limited is a private limited company based in Pimpri, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2016PTC158796. Its GSTIN is 27AADCH8411L1ZE (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9 Lakh. It is led by directors including Vishwanath Kadappa Hanji (Managing Director) and Ijaj Abdulgani Khalif.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Fl. B – 07 Sect. 07 Plot 80/5 Arihant Properties Bhosari, Pimpri, Maharashtra, India – 411019.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.12 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net loss of ₹11.03 Lakh (net margin -5.2%) and EBITDA of ₹1.11 Lakh (EBITDA margin 0.5%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 16% over five years.
As per MCA filings, the company has open charges of ₹1 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFl. B – 07 Sect. 07 Plot 80/5 Arihant Properties Bhosari, Pimpri, Maharashtra, India – 411019
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Humanize Pharmaceuticals Private Limited
The main business activity of Humanize Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Humanize Pharmaceuticals Private Limited FY 2025 filings available
Humanize Pharmaceuticals Private Limited reported revenue of ₹2.12 Cr (up 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Humanize Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 11% growth in the latest year. EBITDA fell 87% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Humanize Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.11 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹11.03 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Humanize Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -5.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Humanize Pharmaceuticals are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Humanize Pharmaceuticals Private Limited
Humanize Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Panzer Pharmaceutical Private Limited | ₹2.13 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Rajkot, Gujarat, India |
| Petz Arena Private Limited | ₹2.13 Cr (FY 2024) | •••• | •••• | 2236.0% | •••• | Thiruvananthapuram, Kerala, India |
| Adn Lifesciences Marketing & Selling Private Limited | ₹2.13 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Lucknow, Uttar Pradesh, India |
| Oracle Medicare Private Limited | ₹2.13 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Mumbai, Maharashtra, India |
| Meharwan Pharmacy Private Limited | ₹2.12 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Ulhasnagar, Maharashtra, India |
| Humanize Pharmaceuticals Private Limited this company | ₹2.12 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Pimpri, Maharashtra, India |
| Ash Healthcare Private Limited | ₹2.12 Cr (FY 2025) | •••• | •••• | 86.0% | •••• | New Delhi, Delhi, India |
| Norwell Pharma Private Limited | ₹2.12 Cr (FY 2025) | •••• | •••• | 49.0% | •••• | Hyderabad, Telangana, India |
| Ebc Pharmaceuticals Private Limited | ₹2.12 Cr (FY 2025) | •••• | •••• | 50.0% | •••• | Thrissur, Kerala, India |
| Kapsons Homeopathic Private Limited | ₹2.12 Cr (FY 2025) | •••• | •••• | 51.0% | •••• | New Delhi, Delhi, India |
| Arehk Healthcare Private Limited | ₹2.12 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | Agra, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Humanize Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Humanize Pharmaceuticals Private Limited
Humanize Pharmaceuticals Private Limited is audited by N T SHELAKE & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| N T SHELAKE & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Humanize Pharmaceuticals Private Limited
Humanize Pharmaceuticals has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ijaj Abdulgani Khalif | Director | 11 Mar 2016 | 10 Years 7 Months | Current |
| Prithviraj Bhupal Desai | Director | 11 Mar 2016 | 10 Years 7 Months | Current |
| Vishwanath Kadappa Hanji Also directs: Gadhinglaj Pharma LLP | Managing Director | 11 Mar 2016 | 10 Years 7 Months | Current |
| Ajit Ramrao Desai | Director | 11 Mar 2016 | 10 Years 7 Months | Current |
| Swati Gajendra Bandi | Director | 11 Mar 2016 | 10 Years 7 Months | Current |
Ownership and Shareholding of Humanize Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Humanize Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Mar 2025 | Others | ₹1 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Humanize Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Humanize Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Humanize Pharmaceuticals Private Limited
Humanize Pharmaceuticals Private Limited has 11 board changes on record since 2016: 5 appointments and 6 cessations. The latest: Ijaj Abdulgani Khalif ceased to be Director on 24 Feb 2025.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Humanize Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Humanize Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Humanize Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Humanize Pharmaceuticals Private Limited
Humanize Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCH8411L1ZE | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Humanize Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Humanize Pharmaceuticals Private Limited
Humanize Pharmaceuticals is an active private limited company based in Pimpri, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 March 2016 (10+ years old) and is registered under CIN U74999PN2016PTC158796.
Humanize Pharmaceuticals reported revenue of ₹2.12 Cr for FY 2025 (up 11% YoY).
Humanize Pharmaceuticals has 5 current directors:
- Vishwanath Kadappa Hanji - Managing Director
- Ijaj Abdulgani Khalif - Director
- Prithviraj Bhupal Desai - Director
- Ajit Ramrao Desai - Director
- Swati Gajendra Bandi - Director
Humanize Pharmaceuticals reported a net loss of ₹11.03 Lakh (net margin -5.2%) and EBITDA of ₹1.11 Lakh (EBITDA margin 0.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Humanize Pharmaceuticals is 13% over three years and 16% over five years. In the latest year (FY 2025) revenue rose 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Humanize Pharmaceuticals is 27AADCH8411L1ZE, registered in Maharashtra.
The CIN (Corporate Identification Number) of Humanize Pharmaceuticals is U74999PN2016PTC158796. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Humanize Pharmaceuticals was incorporated on 11 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Humanize Pharmaceuticals by revenue are Panzer Pharmaceutical Private Limited, Petz Arena Private Limited, Adn Lifesciences Marketing & Selling Private Limited, Oracle Medicare Private Limited, Meharwan Pharmacy Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Ijaj Abdulgani Khalif ceased to be Director on 24 Feb 2025. Pradeep Balkrishna Sankpal ceased to be Director on 24 Feb 2025. Swati Gajendra Bandi ceased to be Director on 24 Feb 2025. Humanize Pharmaceuticals has 11 board changes on record in total.
The registered office of Humanize Pharmaceuticals is at Fl. B – 07 Sect. 07 Plot 805 Arihant Properties Bhosari, Pimpri, Maharashtra, India – 411019.